MARK S. ORDAN - 12 Jan 2025 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role: Chief Executive Officer, Director
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Issuer symbol: MD
Transactions as of: 12 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 14 Jan 2025, 17:30:11 UTC
Previous filing: 14 Nov 2024
Next filing: 02 May 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MD	Performance Share Unit	Award	$0	+640,000		$0.000000	640,000	12 Jan 2025	Common Stock	640,000		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both a service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to 125%, 150% and 175% of $13.55 for at least 20 consecutive trading days before the third anniversary of the grant date.

Content

Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both a service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to 125%, 150% and 175% of $13.55 for at least 20 consecutive trading days before the third anniversary of the grant date.